BACKGROUND: Bariatric surgery rapidly induces improvements in type 2 diabetes (T2D) in concert with reduction in systemic markers of inflammation. The impact of bariatric surgery on local intestinal immunity is not known. We hypothesize that sleeve gastrectomy (SG) and gastric bypass (RYGB) surgeries resolve obesity-induced intestinal inflammation, thereby promoting T2D resolution. METHODS: SG and RYGB, or control surgery was performed in SD rats (n = 4-6/group). Key cytokines involved in insulin resistance (TNF-α, IFN-γ), inflammasome activation (IL-1β, IL-18), inflammation resolution (IL-10, IL-33), and Th17 cell responses (IL-17, IL-23) were measured by qPCR in mucosal scrapings of jejunum at 4 weeks post-surgery. Intestinal cytokine expressions were correlated with weight change, systemic and portal glucose, and insulin levels in response to an enteral glucose load. RESULTS: SG downregulated IL-17 and IL-23 in both proximal and distal jejunum, and IFN-γ was reduced only in distal jejunum (p < 0.05). Jejunal IL-17 and IL-23 expression correlated positively with weight changes after SG (0.93 and 0.98, respectively; p < 0.05). Changes in IFN-γ correlated strongly with insulin levels in portal and systemic circulation (0.99 and 0.95, respectively, p < 0.05). As with SG, IFN-γ, IL-17, and IL-23 were significantly reduced by RYGB. RYGB also reduced TNF-α and IL-18 and increased IL-33 levels (p < 0.05). CONCLUSIONS: RYGB and SG reduce expression of pro-inflammatory cytokines IL-17, IL-23, and IFN-γ in the jejunum. RYGB showed attenuation of additional pro-inflammatory cytokines and enhanced expression of IL-33. Post-surgical changes in intestinal IL-17, IL-23, and IFN-γ correlate strongly with changes in weight and glucose-triggered insulin responses.
BACKGROUND: Bariatric surgery rapidly induces improvements in type 2 diabetes (T2D) in concert with reduction in systemic markers of inflammation. The impact of bariatric surgery on local intestinal immunity is not known. We hypothesize that sleeve gastrectomy (SG) and gastric bypass (RYGB) surgeries resolve obesity-induced intestinal inflammation, thereby promoting T2D resolution. METHODS: SG and RYGB, or control surgery was performed in SD rats (n = 4-6/group). Key cytokines involved in insulin resistance (TNF-α, IFN-γ), inflammasome activation (IL-1β, IL-18), inflammation resolution (IL-10, IL-33), and Th17 cell responses (IL-17, IL-23) were measured by qPCR in mucosal scrapings of jejunum at 4 weeks post-surgery. Intestinal cytokine expressions were correlated with weight change, systemic and portal glucose, and insulin levels in response to an enteral glucose load. RESULTS: SG downregulated IL-17 and IL-23 in both proximal and distal jejunum, and IFN-γ was reduced only in distal jejunum (p < 0.05). Jejunal IL-17 and IL-23 expression correlated positively with weight changes after SG (0.93 and 0.98, respectively; p < 0.05). Changes in IFN-γ correlated strongly with insulin levels in portal and systemic circulation (0.99 and 0.95, respectively, p < 0.05). As with SG, IFN-γ, IL-17, and IL-23 were significantly reduced by RYGB. RYGB also reduced TNF-α and IL-18 and increased IL-33 levels (p < 0.05). CONCLUSIONS: RYGB and SG reduce expression of pro-inflammatory cytokines IL-17, IL-23, and IFN-γ in the jejunum. RYGB showed attenuation of additional pro-inflammatory cytokines and enhanced expression of IL-33. Post-surgical changes in intestinal IL-17, IL-23, and IFN-γ correlate strongly with changes in weight and glucose-triggered insulin responses.
Entities:
Keywords:
Cytokines; Glucose; Insulin and weight; RYGB; SG
Authors: Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap Journal: N Engl J Med Date: 2017-02-16 Impact factor: 91.245
Authors: Helen Luck; Sue Tsai; Jason Chung; Xavier Clemente-Casares; Magar Ghazarian; Xavier S Revelo; Helena Lei; Cynthia T Luk; Sally Yu Shi; Anuradha Surendra; Julia K Copeland; Jennifer Ahn; David Prescott; Brittany A Rasmussen; Melissa Hui Yen Chng; Edgar G Engleman; Stephen E Girardin; Tony K T Lam; Kenneth Croitoru; Shannon Dunn; Dana J Philpott; David S Guttman; Minna Woo; Shawn Winer; Daniel A Winer Journal: Cell Metab Date: 2015-04-07 Impact factor: 27.287
Authors: Danny Ben-Zvi; Luca Meoli; Wasif M Abidi; Eirini Nestoridi; Courtney Panciotti; Erick Castillo; Palmenia Pizarro; Eleanor Shirley; William F Gourash; Christopher C Thompson; Rodrigo Munoz; Clary B Clish; Ron C Anafi; Anita P Courcoulas; Nicholas Stylopoulos Journal: Cell Metab Date: 2018-06-28 Impact factor: 27.287
Authors: Shengli Ding; Michael M Chi; Brooks P Scull; Rachael Rigby; Nicole M J Schwerbrock; Scott Magness; Christian Jobin; Pauline K Lund Journal: PLoS One Date: 2010-08-16 Impact factor: 3.240
Authors: Tammy Lo; Renuka S Haridas; Eleanor J M Rudge; Robert P Chase; Keyvan Heshmati; Elizabeth M Lucey; Alison M Weigl; Otatade J Iyoha-Bello; Chelsea O Ituah; Emily J Benjamin; Seth W McNutt; Leena Sathe; Leanna Farnam; Benjamin A Raby; Ali Tavakkoli; Damien C Croteau-Chonka; Eric G Sheu Journal: J Clin Endocrinol Metab Date: 2022-01-18 Impact factor: 6.134
Authors: David A Harris; Amir Mina; Dimitrije Cabarkapa; Keyvan Heshmati; Renuka Subramaniam; Alexander S Banks; Ali Tavakkoli; Eric G Sheu Journal: Am J Physiol Endocrinol Metab Date: 2020-02-18 Impact factor: 4.310
Authors: Tammy Lo; Eleanor J M Rudge; Robert P Chase; Renuka Subramaniam; Keyvan Heshmati; Elizabeth M Lucey; Alison M Weigl; Otatade J Iyoha-Bello; Chelsea O Ituah; Emily J Benjamin; Seth W McNutt; Leena Sathe; Leanna Farnam; Benjamin A Raby; Ali Tavakkoli; Damien C Croteau-Chonka; Eric G Sheu Journal: medRxiv Date: 2020-11-03
Authors: Petros Katsogiannos; Prasad G Kamble; Maria J Pereira; Magnus Sundbom; Per-Ola Carlsson; Jan W Eriksson; Daniel Espes Journal: Obesity (Silver Spring) Date: 2021-03 Impact factor: 5.002